GPT and metabolic dysfunction-associated steatotic liver disease: In conclusion, this study showed the efficacy of the administration of the association of silymarin, vitamin C, vitamin E, coenzyme Q10 and selenomethionine (Medronys epato®) in the improvement of hepatic function of NAFLD patients, as evaluated by a significant reduction of liver enzymes (ALT, AST, ALP and GGT), by a significant improvement of lipid parameters (TC, C-LDL, HDL-C and TG) analyzed as markers of liver function and by the improvements of liver ultrasonography.